Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon?

J Manag Care Pharm. 2010 Jul-Aug;16(6):417-23. doi: 10.18553/jmcp.2010.16.6.417.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Primary Prevention / methods*
  • Randomized Controlled Trials as Topic / standards

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors